GBI Research Market Research Reports

Title published price

Frontier Pharma: Orphan and Rare Dermatological Diseases - First-in-Class Therapies Demonstrate Potential Disease-Modifying Effects in Areas of High Unmet Need Such as Epidermolysis Bullosa

By GBI Research

Orphan and rare dermatological diseases are considerably diverse in terms of pathophysiology, clinical presentation and disease severity. Many of these conditions are extremely debilitating and can even be life-threatening in some cases. D ...

11-Oct-2018 $6995

Dermatological Burns, Scars and Ulcers Drug Development Pipeline Review, 2018

By GBI Research

This report provides an overview of the pipeline landscape for dermatological burns, scars and ulcers. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for pressure ulc ...

28-Sep-2018 $3995

Pain Drug Development Pipeline Review, 2018

By GBI Research

This report provides an overview of the pipeline landscape for pain disorders. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for post-operative pain, fibromyalgia, c ...

24-Sep-2018 $3995

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018

By GBI Research

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for depression and anxiety disorders. It provides comprehensive information on th ...

21-Sep-2018 $3995

Global Orphan and Rare Dermatology Drugs Market to 2024 - An Increasingly Competitive Landscape as New Companies Enter the Market with Novel Products, Driving Strong Market Growth

By GBI Research

Global Orphan and Rare Dermatology Drugs Market to 2024 - An Increasingly Competitive Landscape as New Companies Enter the Market with Novel Products, Driving Strong Market Growth Summary Dermatology is a highly diverse ...

01-Sep-2018 $4995

Heart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy

By GBI Research

Heart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy Summary Heart failure (HF) is a life-threatening syndrome with ...

01-Sep-2018 $4995

Blood Pressure Disorders Drug Development Pipeline Review, 2018

By GBI Research

Blood Pressure Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for blood pressure disorders. It provides comprehensive information on the therapeutics under ...

31-Aug-2018 $3995

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

By GBI Research

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for pancreatic and bile duct cancer. It provides comprehensive information on the ther ...

31-Aug-2018 $3995

Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness

By GBI Research

Summary Osteoporosis is a “silent epidemic” and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of co ...

01-Aug-2018 $4995

Respiratory Tract Infections Drug Development Pipeline Review, 2018

By GBI Research

Respiratory Tract Infections Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for respiratory tract infections. It provides comprehensive information on the therapeuti ...

31-Jul-2018 $3995

Mucopolysaccharidosis Disorders Drug Development Pipeline Review, 2018

By GBI Research

Mucopolysaccharidosis Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for mucopolysaccharidosis disorders, a group of inherited lysosomal storage disorders. ...

30-Jul-2018 $3995

Diarrhea and Constipation Drug Development Pipeline Review, 2018

By GBI Research

Diarrhea and Constipation Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for diarrhea and constipation. It provides comprehensive information on the therapeutics und ...

30-Jul-2018 $3995

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

By GBI Research

Colorectal cancer (CRC) is the most common cancer and the leading cause of cancer-related mortality globally. The five-year prevalence population for CRC in Asia-Pacific was 1.7 million in 2017. This figure has been gradually rising with the growi ...

01-Jul-2018 $4995

Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer

By GBI Research

Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer Summary Breast cancer remains a major global healthcare concern despi ...

01-Jul-2018 $6995

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline

By GBI Research

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline Summary Cancer immunotherapy, which can predominantly be classed as a form ...

01-Jul-2018 $4995

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018

By GBI Research

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for diabetes and associated metabolic conditions. It provides comprehensi ...

29-Jun-2018 $3995

Menopausal Disorders Drug Development Pipeline Review, 2018

By GBI Research

Menopausal Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for menopausal disorders. It provides comprehensive information on the therapeutics under develop ...

29-Jun-2018 $3995

Hepatitis Drug Development Pipeline Review, 2018

By GBI Research

Hepatitis Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for hepatitis infections. It provides comprehensive information on the therapeutics under development and ke ...

29-Jun-2018 $3995

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

By GBI Research

Psoriasis is a common, chronic inflammatory skin condition affecting around 2-3% of the world’s population. While the main cause of psoriasis remains uncertain, immunologic, genetic, and environmental factors appear to play a role. Common sy ...

01-Jun-2018 $4995

Mosquito-borne Diseases Drug Development Pipeline Review, 2018

By GBI Research

Mosquito-borne Diseases Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for mosquito-borne diseases and comprehensive information on the therapeutics under developmen ...

24-May-2018 $3995